Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P17
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -7.45% |
| 2024 | -10.76% |
| 2023 | 26.66% |
| 2022 | 42.62% |
| 2021 | 78.50% |
| 2020 | 53.32% |
| 2019 | 0.00% |